当前位置：
X-MOL 学术
›
Eur. Urol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in Preclinical Models of Bladder Cancer
European Urology ( IF 23.4 ) Pub Date : 2024-03-23 , DOI: 10.1016/j.eururo.2024.03.013 Yuzhen Zhou , Vincent D. D'Andrea , Surish P. Shanmugam , Isabella Stelter , Dag R. Stormoen , Rea Chroneos , Timothy Hanlon , Ilana Epstein , Raie T. Bekele , William J. Anderson , Filipe F.L. Carvalho , Joaquim Bellmunt , Kent W. Mouw
中文翻译：
Enfortumab Vedotin 和 Sacituzumab Govitecan 在膀胱癌临床前模型中的放射活性
更新日期：2024-03-23
European Urology ( IF 23.4 ) Pub Date : 2024-03-23 , DOI: 10.1016/j.eururo.2024.03.013 Yuzhen Zhou , Vincent D. D'Andrea , Surish P. Shanmugam , Isabella Stelter , Dag R. Stormoen , Rea Chroneos , Timothy Hanlon , Ilana Epstein , Raie T. Bekele , William J. Anderson , Filipe F.L. Carvalho , Joaquim Bellmunt , Kent W. Mouw
中文翻译：
Enfortumab Vedotin 和 Sacituzumab Govitecan 在膀胱癌临床前模型中的放射活性
京公网安备 11010802027423号